Technological advancements are enhancing the detection of fibrosis. Elastography, an imaging technique that assesses tissue stiffness, is gaining traction due to its non-invasive nature and efficacy in detecting liver fibrosis. Moreover, omics technologies, including genomics, proteomics, and metabolomics, are being leveraged to identify novel biomarkers and pathways involved in fibrosis.
In conclusion, the detection of fibrosis in toxicology is critical for understanding the impact of toxicants on human health. While challenges remain, ongoing research and technological innovations hold promise for improving the detection and management of fibrosis, ultimately aiding in the prevention of related diseases.
